ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

Ursula A. Matulonis, Julie Lee, Brian Lasonde, William P. Tew, Afra Yehwalashet, Daniela Matei, Kian Behbakht, Jill Grothusen, Gini Fleming, Nita K. Lee, Jamie Arnott, Mark R. Bray, Graham Fletcher, Richard D. Brokx, Vincent Castonguay, Helen MacKay, Carolyn F. Sidor, Amit M. Oza

Research output: Contribution to journalArticle

28 Scopus citations

Fingerprint Dive into the research topics of 'ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences